{
 "name": "宇越生醫",
 "slug": "tw-7902",
 "aliases": [
  "宇越生醫科技股份有限公司",
  "UWELL",
  "7902"
 ],
 "ticker": "7902",
 "industry": "生技醫療業",
 "website": "http://www.uwell.com.tw/",
 "summary": "宇越生醫（7902）是興櫃的生技醫療類股公司，2020 年成立，2026 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "宇越生醫科技股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "UWELL",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2026-01-22",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2020-12-08",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "秦嘉鴻",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "龐德玲",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 200605000,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "http://www.uwell.com.tw/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "管線：UWC19（Welgenaleucel；非霍奇金淋巴瘤）",
   "value": "復發或難治B細胞非霍奇金淋巴瘤｜二期臨床申請未獲同意執行，擬調整計畫重新申請｜台灣",
   "unit": "",
   "as_of": "2026-09-11",
   "source": "https://mopsov.twse.com.tw/mops/web/ajax_t05st01?seq_no=1&spoke_time=190517&spoke_date=20260911&TYPEK=rotc&firstin=true&step=2&co_id=7902&year=115&month=all&e_month=all",
   "note": "發言日期115/09/11 19:05:17；主旨：本公司Welgenaleucel (UWC19)申請供查驗登記用二期臨床 試驗一案，接獲衛福部來函未能同意執行，得另行檢齊資料後， 重新提出申請。；序號1。衛授食字第1159048047號。以較新公告更新1月法說二期計畫，不將未核准試驗列為進行中。相關早期一期登錄NCT04296461。"
  },
  {
   "claim": "管線：UWC19（Welgenaleucel；自體免疫疾病）",
   "value": "自體免疫疾病｜IND申請階段（法說圖示）｜地區未揭露",
   "unit": "",
   "as_of": "2026-01-15",
   "source": "https://www.uwell.com.tw/_i/assets/upload/files/%E6%B3%95%E8%AA%AA%E6%9C%83%E7%B0%A1%E5%A0%B1.pdf",
   "note": "公司官網法人說明會列表標示2026/01/15；PDF第24頁臨床開發進程圖已視覺核對。來源未明示此用途研發地區，不依公司所在地推定。UWN2D相關舊登錄NCT04717999狀態UNKNOWN，不當作現在仍收案。"
  },
  {
   "claim": "管線：UWN2D（NKG2D CAR-T）",
   "value": "膠質母細胞瘤、胰臟癌｜臨床前研究（法說圖示）｜地區未揭露",
   "unit": "",
   "as_of": "2026-01-15",
   "source": "https://www.uwell.com.tw/_i/assets/upload/files/%E6%B3%95%E8%AA%AA%E6%9C%83%E7%B0%A1%E5%A0%B1.pdf",
   "note": "公司官網法人說明會列表標示2026/01/15；PDF第24頁臨床開發進程圖已視覺核對。來源未明示此用途研發地區，不依公司所在地推定。UWN2D相關舊登錄NCT04717999狀態UNKNOWN，不當作現在仍收案。"
  },
  {
   "claim": "管線：UWFAP（FAP CAR-T）",
   "value": "肝硬化｜臨床前研究（法說圖示）｜地區未揭露",
   "unit": "",
   "as_of": "2026-01-15",
   "source": "https://www.uwell.com.tw/_i/assets/upload/files/%E6%B3%95%E8%AA%AA%E6%9C%83%E7%B0%A1%E5%A0%B1.pdf",
   "note": "公司官網法人說明會列表標示2026/01/15；PDF第24頁臨床開發進程圖已視覺核對。來源未明示此用途研發地區，不依公司所在地推定。UWN2D相關舊登錄NCT04717999狀態UNKNOWN，不當作現在仍收案。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-7902.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}